Thomas Lew, MD, ABIM

Thomas Lew, MD, ABIM, assistant clinical professor of medicine at the Stanford University School of Medicine

Articles by Thomas Lew, MD, ABIM

Measles, Measles Outbreak, Measles Surge, Vaccine Hesitancy

The Pharmacist’s Role Amid Measles Surge, Vaccine Policy Change

ByBrian Nowosielski,Thomas Lew, MD, ABIM,Molly O’Shea, MD, FAAP,Jesse Goodman, MD, MPH

September 10th 2026

Thomas Lew, MD, ABIM, Molly O’Shea, MD, FAAP, and Jesse Goodman, MD, MPH, discuss vaccine policy changes and their impact on measles outbreaks.

Measles, Measles Symptoms, Measles Outbreak

How Pharmacists Can Address Measles Misinformation with Patients

ByBrian Nowosielski,Thomas Lew, MD, ABIM

September 7th 2026

In part 1 of our series, Thomas Lew, MD, ABIM, explores the optimal approaches to meandering vaccine hesitancy amid increasing measles cases.

Latest Updated Articles

Trending on Drug Topics

PBM Underpayment Persists as Cost-Plus Brings New Strain | NCPA 2026

Q&A: Why Enforcement Is the Weak Link in State PBM Reform | NCPA 2026

Pharmacist Roles, Risks in Guiding AI-Enabled Medical Device Use

PBM Network Terminations Bring Risks Beyond Lost Contracts | NCPA 2026

FDA Approves Bepirovirsen Injection to Treat Chronic Hepatitis B